<?xml version="1.0" encoding="UTF-8"?>
<p>Nafamostat is a potent inhibitor of MERS-CoV that acts by preventing membrane fusion. Nevertheless, it does not have any sort of inhibitory action against SARS-CoV-2 infection (
 <xref rid="B194" ref-type="bibr">194</xref>). Recently, several newly synthesized halogenated triazole compounds were evaluated, using fluorescence resonance energy transfer (FRET)-based helicase assays, for their ability to inhibit helicase activity.
</p>
